Skip to main content
Connie Price, MD, Infectious Disease, Denver, CO, Denver Health

ConnieSPriceMD

Infectious Disease Denver, CO

Healthcare Associated Infections, Microbiology

Chief Medical Officer at Denver Health and Professor of Medicine (Infectious Diseases) University of Colorado School of Medicine

Dr. Price is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Price's full profile

Already have an account?

Summary

  • Connie Savor Price, MD is the Chief Medical Officer (CMO) at Denver Health and a Professor of Medicine in the Division of Infectious Diseases at the University Of Colorado School Of Medicine. Prior to becoming the CMO, she served as the Chief of Infectious Diseases and the Medical Director of Infection Control and Prevention at Denver Health for 13 years. Dr. Price is board-certified in infectious diseases and medical microbiology. Her research and clinical interest focuses in healthcare epidemiology and methods to prevent and rapidly detect emerging and antimicrobial resistant infections. Dr. Price has a track record of successful federal funding as a Principal Investigator from the National Institutes of Health, the Department of Defense, and the Agency for Healthcare Research and Quality. She has published > 75 manuscripts and delivered >175 lectures on the prevention of healthcare associated infectious diseases and related topics. She is active in the Infectious Diseases Society of America, served in an elected position on the Board of Directors of the Society of Healthcare Epidemiology of America, and as past chair of the American Society for Microbiology section on Healthcare Epidemiology. Dr Price was the physician representative on the inaugural Colorado Healthcare Associated Infections advisory committee for public reporting of healthcare associated infections for Colorado. She has recognized expertise in outbreak management and has served as a consultant to public health authorities around the world on control of emerging infections, specifically MERS and SARS, as well as Ebola preparedness.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Medical Microbiology, 2001
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2000
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1995 - 1998
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 1995 - 1996
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1995

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2002 - 2025
  • IL State Medical License
    IL State Medical License 1995 - 2002
  • VA State Medical License
    VA State Medical License 1999 - 2000
  • American Board of Internal Medicine Infectious Disease
  • American Board of Pathology Medical Microbiology

Awards, Honors, & Recognition

  • Best Doctors of America Best Doctors, 2011-2018
  • Selected by peers as a Peak Performer The Rocky Mountain Hospital Medicine Symposium (RMHMS), 2010, 2013-2014
  • CEO Award for “For extraordinary commitment to the health and treatment of our patients” Denver Health, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic data.  
    Savor C, Pfaller MA, Kruszynski JA, Hollis RJ, Noskin GA, Peterson LR, J Clin Microbiol
  • Successful Limb-Sparing Treatment Strategy for Diabetic Foot Osteomyelitis.  
    Beieler A, Jenkins T, Saveli C, Bruntz M, Belknap R, Price CS, the Journal of the American Podiatric Medical Association
  • Anthonisen NR for the COPD Clinical Research Network. Azithromycin for Prevention of COPD Exacerbations.  
    Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JAD, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy..., . N Engl J Med
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Preparations of Potential Intermediates for the Synthesis of Pradimicin In: Program and abstracts of the Pew Midstates Science and Mathematics Consortium, Chemistry R...
    Savor C, Callen G, Parker K, Holland, MI: Pew Consortium
  • The Role of Fibronectin in Cellular Aging. In: Program and abstracts of the Pew Midstates Science and Mathematics Consortium, Biology Research Symposium (Chicago).
    Savor C and Smith J, Holland, MI: Pew Consortium
  • Necrotizing Fasciitis Caused by Staphylococcus aureus as a Single Pathogen. In: Program and abstracts of the 37th Meeting of the Infectious Disease Society of Americ...
    Savor C and Tuazon C, Washington, DC: American Society for Microbiology
  • Join now to see all

Lectures

  • Bringing Value Through BioSense- Initial Findings from the Johns Hopkins Evaluation Team PH 
    Preparedness Summit, Session #138, Atlanta, GA
  • The Potential Financial Impact of Public Reporting on Physicians and Hospitals. 
    The Creighton University School of Medicine 28th Annual Infectious Diseases Symposium
  • Clostridium difficile Infection: An Update on Treatment Guidelines and Management of the Severe Patient. 
    Longview, WA
  • Join now to see all

Hospital Affiliations